Iron Homeostasis and Liver Diseases
Open Access
- 21 October 2026
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (20) , e71412
Abstract
Iron is an essential micronutrient whose ability to cycle between ferric (Fe 3+ ) and ferrous (Fe 2+ ) states makes it crucial for physiological processes, including oxygen transport, DNA synthesis, and oxidative phosphorylation. However, because both deficiency and excess can cause severe pathology, precise regulation is critical. The liver plays a central role in systemic iron metabolism, and growing evidence identifies hepatic iron dyshomeostasis as a key catalyst in diverse liver disorders, including metabolic dysfunction‐associated steatotic liver disease (MASLD/MASH), alcoholic liver disease, liver fibrosis, and hepatocellular carcinoma (HCC). Hepatic iron accumulation promotes liver injury primarily through oxidative stress, mitochondrial dysfunction, and ferroptosis. In this review, we synthesize the multi‐layered regulatory landscape of hepatic iron homeostasis, encompassing systemic coordination, cellular fine‐tuning, and epigenetic modifications. We thoroughly dissect the pathogenic impact of iron overload and critically evaluate emerging therapeutic strategies aimed at restoring iron balance, such as hepcidin mimetics and ferroptosis modulators. Finally, we discuss current literature gaps—including preclinical model limitations, the lack of standardized non‐invasive biomarkers, and drug delivery bottlenecks—providing a clear roadmap for future translational research in iron‐related liver pathologies.Keywords
Funding Information
- National Natural Science Foundation of China (82372810)
- National Natural Science Foundation of China (82403007)
- National Natural Science Foundation of China (82273089)
- Kunming Medical University (2024XKTDYS04)
- Kunming Medical University (KLTIPT‐2023‐03)
- Yunnan University (YDYXJJ2024‐0006)
- Yunnan University (KC‐242410510)
This publication has 367 references indexed in Scilit:
- Recent Advancements in Known and Emerging Risk Factors of Hepatocellular CarcinomaCancer Medicine, 2025
- Proteolysis‐triggered RNA Interference for Mitochondrial Iron Dyshomeostasis to Activate Antitumor Immunity in Hepatic CarcinomaAdvanced Materials, 2025
- Mesenchymal Stem Cells Prevent SLC39A14‐Dependent Hepatocyte Ferroptosis through Exosomal miR‐16‐5p in Liver GraftAdvanced Science, 2024
- Iron‐triggered signaling via ETS1 and the p38/JNK MAPK pathway regulates Bmp6 expressionAmerican Journal of Hematology, 2024
- Diagnosis and Management of Hereditary HemochromatosisJAMA, 2022
- Iron controls T helper cell pathogenicity by promoting glucose metabolism in autoimmune myopathyClinical and Translational Medicine, 2022
- The small molecule, genistein, increases hepcidin expression in human hepatocytesHepatology, 2013
- Hepatocyte Divalent Metal-Ion Transporter-1 Is Dispensable for Hepatic Iron Accumulation and Non-Transferrin-Bound Iron Uptake in MiceHepatology, 2013
- A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE -Related Hereditary HemochromatosisHepatology, 2010
- Differential regulation of iron homeostasis during human macrophage polarized activationEuropean Journal of Immunology, 2010